AU2021204135B2 — Dispersible compositions
Assigned to Janssen Pharmaceutica NV · Expires 2023-10-05 · 3y expired
What this patent protects
The present invention is concerned with dispersible compositions comprising bedaquiline 5 fumarate as an active ingredient. Such compositions are useful in the treatment of tuberculosis and their inherent dispersibility properties lend themselves to be useful in particular amo…
USPTO Abstract
The present invention is concerned with dispersible compositions comprising bedaquiline 5 fumarate as an active ingredient. Such compositions are useful in the treatment of tuberculosis and their inherent dispersibility properties lend themselves to be useful in particular amongst the pediatric or geriatric population.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.